Anesthesiology Doctors in Indian Harbour Beach, FL Accepting Medicare

2 Anesthesiology doctors found. Showing 1 - 2

Dr. Christopher Clarence Thessen, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 249 Lansing Island Dr, Indian Harbour Beach, FL 32937 Phone: 321-242-9599    Fax: 321-242-9599

Frederick Daniel Rochman, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 2225 Highway A1a Apt 308, Indian Harbour Beach, FL 32937 Phone: 715-209-2249    Fax: 321-733-7970

News Archive

Study evaluates screening and treatment for subclinical thyroid disease during pregnancy

Observational studies over the past 30 years suggest that subclinical thyroid disease during pregnancy may be associated with adverse outcomes, including a lower-than-normal IQ in offspring.

Survey reveals negative impact of uncertain policy surrounding human embryonic stem cell research

While there is no doubt that the ethical controversy surrounding human embryonic stem cell (hESC) research has given rise to an uncertain policy environment, the true impact of years of frequent policy changes has not been fully assessed.

SSH presents series of awards for simulation in healthcare at IMSH

The Society for Simulation in Healthcare presented a series of awards and recognized newly certified professionals this month, all recognizing excellence the field at the International Meeting for Simulation in Healthcare.

FDA confirms Advisory Committee meeting date for lorcaserin NDA review

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.

Cardium's Excellagen topical gel for diabetic foot ulcers receives FDA 510(k) clearance

Cardium Therapeutics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company's new Excellagen™ professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds.

Read more Medical News

› Verified 1 days ago